Alnylam Pharmaceuticals | ALNY - 股本和储备



金融业
股票价格
USD
资产
USD 5.56B
现金及等价物
USD 1.71B
销售成本
USD 298.45M
流动资产
USD 4.62B
流动负债
USD 1.51B
债务
USD 1.27B
EBIT
USD 112.6M
EBITDA
USD 245.34M
员工
2.23K
EPS每股收益
USD 1.84
股本和储备
USD 1.35B
销售毛利
USD 992.69M
债务利息支出
USD 82.05M
利息收入
USD 26.6M
贷款资金
USD 2.47B
市值
USD 30.71B
净收入
USD 164.49M
营业费用
USD 1.06B
营业利润
USD 112.6M
普通股股本
USD 133.73M
PE价格收益
75.64
税前利润
USD 177.81M
销售收入
USD 1.29B
销售和管理费用
USD 347.92M
股票
USD 97.11M
贸易债权人
USD 108.02M
应收帐款人
USD 912.74M


股本和储备 更改 日
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amgen USD 11.69B 2.5B 2026-06
Arrowhead Research USD 465.53M 148.45M 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Moderna USD 6.76B 647M 2026-06
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Novartis USD 38.93B 7.2B 2026-03
PTC Therapeutics USD -165.36M 15.1M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 73.14B 1.43B 2026-03
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Takeda JPY 7.56T 215.7B 2026-06
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06
Xencor USD 503.23M 12.4M 2026-06